Roderick Wong is Managing Partner and Chief Investment Officer of RTW Investments. See sector focus.
Roderick Wong is Managing Partner and Chief Investment Officer of RTW Investments, and SEC filings identify him as an executive officer of RTW Innovation Onshore Fund, based in New York. RTW says he manages investments focused on innovative drug development, and outside coverage describes the firm as a specialist life sciences investor with a global portfolio, but the exact stage and geography focus for the onshore fund are not clearly disclosed in the available sources. A third-party investor database lists an investment range of $10 million to $50 million and a sweet spot of $25 million, though this is not confirmed by RTW. Named investments visible in the record include Jixing Pharmaceuticals and Milestone Pharmaceuticals, and other RTW-linked holdings mentioned in current coverage include Beta Bionics, Beam Therapeutics, Verona Pharma, Rocket Pharmaceuticals, and GE HealthCare Technologies. Wong has also been described publicly as arguing that biotech is entering a new phase of maturity and as emphasizing scientific diligence in evaluating innovation. He previously held healthcare investment and research roles at Davidson Kempner, Sigma Capital Partners, and Cowen & Company bef
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in New York.
Investors like Roderick Wong · Full investor directory · Investor access · Company funding database